Long non‑coding RNA‑ZNF281 upregulates PTEN expression via downregulation of microRNA‑221 in non‑small cell lung cancer

Lu,Xin; Yin,Bin; Wang,Xuekun; Wang,Fengchan; Li,Yue; Wang,Na; Yang,Xinai; Jiang,Wenqing

doi:10.3892/ol.2020.11821

Long non‑coding RNA‑ZNF281 upregulates PTEN expression via downregulation of microRNA‑221 in non‑small cell lung cancer

Authors:
- Xin Lu
- Bin Yin
- Xuekun Wang
- Fengchan Wang
- Yue Li
- Na Wang
- Xinai Yang
- Wenqing Jiang
View Affiliations

Affiliations: Department of Respiratory Diseases, Hiser Medical Center of Qingdao, Qingdao, Shandong 266000, P.R. China, Department of Cardiology, Qingdao Central Hospital, Qingdao, Shandong 266000, P.R. China
Published online on: July 7, 2020 https://doi.org/10.3892/ol.2020.11821
Pages: 2962-2968

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

A recent study reported that zinc finger protein (ZNF)281 is a tumor‑suppressive long non‑coding (lnc)RNA in glioma. The present study investigated the role of ZNF281 in non‑small cell lung cancer (NSCLC). ZNF281 expression in paired cancer and non‑cancerous tissues from patients with NSCLCs was analyzed by RNA extraction and reverse transcription‑quantitative‑PCR. A 5‑year follow up on patients was performed to analyze the prognostic value of ZNF281 for NSCLC. Cell transfections of ZNF281 or phosphatase and tensin homolog (PTEN) expression vector and microRNA (miR)‑221 mimic were performed to analyze the relationship between ZNF281, miR‑221 and PTEN. Cell apoptosis and proliferation were analyzed using Cell Counting Kit‑8 and flow cytometry, respectively. In patients with NSCLC, expression levels of ZNF281 were significantly lower in cancer tissues compared with in non‑cancerous tissues, and lower levels of ZNF281 expression in cancerous tissues predicted poor survival. In NSCLC cells, ZNF281 overexpression resulted in upregulated PTEN and downregulated miR‑221 expression, whereas cells with miR‑221 overexpression exhibited downregulated PTEN expression and unaffected ZNF281 expression. In addition, ZNF281 and PTEN overexpression resulted in accelerated cell apoptosis and inhibited the cell proliferation of NSCLC cells. Notably, miR‑221 overexpression exhibited an opposite effect and attenuated the functions of ZNF281 and PTEN overexpression. Therefore, ZNF281 may upregulate PTEN via downregulation of miR‑221 in NSCLC, resulting in inhibition of cancer cell proliferation and the promotion of apoptosis.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
2	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
3	Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R and Jemal A: Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 66:271–289. 2016. View Article : Google Scholar : PubMed/NCBI
4	Herbst RS, Morgensztern D and Boshoff C: The biology and management of non-small cell lung cancer. Nature. 553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
5	Yamamoto H, Yatabe Y and Toyooka S: Inherited lung cancer syndromes targeting never smokers. Transl Lung Cancer Res. 7:498–504. 2018. View Article : Google Scholar : PubMed/NCBI
6	Subramanian J and Govindan R: Molecular genetics of lung cancer in people who have never smoked. Lancet Oncol. 9:676–682. 2008. View Article : Google Scholar : PubMed/NCBI
7	Brennan P, Hainaut P and Boffetta P: Genetics of lung-cancer susceptibility. Lancet Oncol. 12:399–408. 2011. View Article : Google Scholar : PubMed/NCBI
8	Sun H, Lesche R, Li DM, Liliental J, Zhang H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H: PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3, 4, 5,-trisphosphate and Akt/protein kinase B signaling pathway. Proc Natl Acad Sci USA. 96:6199–6204. 1999. View Article : Google Scholar : PubMed/NCBI
9	Carnero A, Blanco-Aparicio C, Renner O, Link W and Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 8:187–198. 2008. View Article : Google Scholar : PubMed/NCBI
10	Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W, Zhi-Fan J, Pei-Yu P, Qing-Yu Z and Chun-Sheng K: MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 10:3672010. View Article : Google Scholar : PubMed/NCBI
11	Li XT, Li JC, Feng M, Zhou YX and Du ZW: Novel lncRNA-ZNF281 regulates cell growth, stemness and invasion of glioma stem-like U251s cells. Neoplasma. 66:118–127. 2019. View Article : Google Scholar : PubMed/NCBI
12	Zhao D, Zhuang N, Ding Y, Kang Y and Shi L: miR-221 activates the NF-κB pathway by targeting A20. Biochem Biophys Res Commun. 472:11–18. 2016. View Article : Google Scholar : PubMed/NCBI
13	Edge SB and Compton CC: The American joint committee on cancer: The 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010. View Article : Google Scholar : PubMed/NCBI
14	Sun Z, Aubry MC, Deschamps C, Marks RS, Okuno SH, Williams BA, Sugimura H, Pankratz VS and Yang P: Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: An analysis of 5018 hospital-and 712 population-based cases. J Thorac Cardiovasc Surg. 131:1014–1020. 2006. View Article : Google Scholar : PubMed/NCBI
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Rinkenbaugh AL and Baldwin AS: The NF-κB pathway and cancer stem cells. Cells. 5:162016. View Article : Google Scholar
17	Li F, Zhang J, Arfuso F, Chinnathambi A, Zayed ME, Alharbi SA, Kumar AP, Ahn KS and Sethi G: NF-κB in cancer therapy. Arch Toxicol. 89:711–731. 2015. View Article : Google Scholar : PubMed/NCBI
18	Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM and Dejean A: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci USA. 107:264–269. 2010. View Article : Google Scholar : PubMed/NCBI
19	Yamashita R, Sato M, Kakumu T, Hase T, Yogo N, Maruyama E, Sekido Y, Kondo M and Hasegawa Y: Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells. Cancer Med. 4:551–564. 2015. View Article : Google Scholar : PubMed/NCBI